Clinical Trial Update: Phase II Trial of Pentostatin and Targeted Busulfan [Phase 2]

View source ↗

Summary

Phase II trial evaluating pentostatin with targeted busulfan in hematologic malignancies has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• BUSULFAN (Busulfan)
• Pentostatin (pentostatin)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Hematologic Malignancies | Phase 2 | Status: COMPLETED | Results posted: 2014-06-05